Factors predicting persistent sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment

International Journal of Tuberculosis and Lung Disease

Volumn 7, Issue 1, 2003, Pages 58-64

  Singla, Rupak ^a,c   Osman, M M ^a   Khan, N ^b   Al Sharif, N ^a   Al Sayegh, M O ^a   Shaikh, M A ^a  

^a Sahary Hospital   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c Green Park Main   (India)

Author keywords

DOT; Predictors; Pulmonary tuberculosis; Smear positivity

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; ADULT; AGE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PREDICTION; PRIORITY JOURNAL; RESOURCE MANAGEMENT; RETROSPECTIVE STUDY; RISK FACTOR; SAUDI ARABIA; SPUTUM SMEAR; THORAX RADIOGRAPHY;

ADULT; DIRECTLY OBSERVED THERAPY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 0037252099     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Rieder H L. Sputum smear conversion during directly observed treatment for tuberculosis. Tubercle Lung Dis 1996; 77: 124-129.
2. Feng-Zeng Z, Levy M H, Sumin W. Sputum microscopy results at two and three months predict outcome of tuberculosis treatment. Int J Tuberc Lung Dis 1997; 1: 570-572.
3. Lienhardt C, Manneh K, Bouchier V, Lahai G, Milligan P J, McAdam K P W J. Factors determining the outcome of treatment of adult smear-positive cases in The Gambia. Int J Tuberc Lung Dis 1998; 2: 712-718.
4. Salaniponi F M, Christensen J J, Gausi F, et al. Sputum smear status at two months and subsequent treatment outcome in new patients with smear-positive pulmonary tuberculosis. Int J Tuberc Lung Dis 1999; 3: 1047-1048.
5. Aber V R, Nunn A J. Short term chemotherapy of tuberculosis: factors affecting relapse following short term chemotherapy. Bull Int Union Tuberc 1978; 53: 276-280.
6. Mitchison D A. Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months [letter]. Am Rev Respir Dis 1993; 147: 1062-1063.
7. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 2nd ed. WHO/CDS/TB/2000.275. Geneva: WHO, 2000.
8. Singla R, Al-Sharif N, Al-Sayegh M O, Osman M M, Shaikh M A. Influence of anti-tuberculosis drug resistance on treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia. Int J Tuberc Lung Dis 2002; 6: 585-591.
9. Epstein M D, Schluger N W, Davidow A L, Bonk S B, Rom W N, Hana B. Time to detection of M. tuberculosis in sputum culture correlate with outcome in patients receiving treatment for pulmonary tuberculosis. Chest 1997; 113: 379-386.
10. Wallis R S, Perkins M, Philips M, et al. Induction of antigen 85 complex of M. tuberculosis in sputum: a determinant of outcome in pulmonary tuberculosis. J Infect Dis 1998; 178: 1115-1121.
11. Wallis R S, Perkins M D, Philips M, et al. Predicting the outcome of therapy for pulmonary tuberculosis. Am J Respir Crit Care Med 2000; 161: 1076-1080.
12. Liu Z, Shilkret K L, Ellis H M. Predictors of sputum culture conversion among patients with tuberculosis in the era of tuberculosis resurgence. Arch Intern Med 1999; 159: 1110-1116.
13. Hobby G I, Holman A P, Iseman M D, Jones J M. Enumeration of tubercle bacilli in sputum of patients with pulmonary tuberculosis. Antimicrob Agents Chemother 1973; 4: 94-104.
14. Vidal R, Martin-Casabonan N, Juan A, Falgueras T, Miravitlles M. Incidence and significance of acid-fast bacilli in sputum smears at the end of antituberculous treatment. Chest 1996; 109: 1562-1565.
15. Hiyama J, Marukawa M, Shiota Y, Ono T, Mashiba H. Factors influencing response to treatment of pulmonary tuberculosis. Acta Med Okayama 2000; 54: 139-145.
16. Telzac E E, Fazal B A, Pollard C L, Turett G S, Justman J E, Blum S. Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis. Clin Infect Dis 1997; 25: 666-670.
17. Bwire R, Borgdorff M W, Sticht-Groh V, et al. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda. East Afr Med J 1999; 76: 307-313.